Efficacy and safety of treatment with omalizumab for chronic spontaneous urticaria ‐ a systematic review for the EAACI Biologicals Guidelines

MLA

Knut Brockow, et al. Efficacy and Safety of Treatment with Omalizumab for Chronic Spontaneous Urticaria ‐ a Systematic Review for the EAACI Biologicals Guidelines. Aug. 2020. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....9e7c579a5a794a5e21fc4b8622648fdd&authtype=sso&custid=ns315887.

APA

Knut Brockow, Pablo Alonso-Coello, Margarita Posso, Thomas Eiwegger, Oscar Palomares, Jessica Beltran, Tomas Chivato, Graham S. Ogg, Marek Jutel, Emma Guttman-Yassky, Ivan Solà, Carlos Canelo-Aybar, Peck Y. Ong, Ioana Agache, Marcus Maurer, Ana Pereira, Jürgen Schwarze, Jan Gutermuth, Kilian Eyerich, … Stefano Del Giacco. (2020). Efficacy and safety of treatment with omalizumab for chronic spontaneous urticaria ‐ a systematic review for the EAACI Biologicals Guidelines.

Chicago

Knut Brockow, Pablo Alonso-Coello, Margarita Posso, Thomas Eiwegger, Oscar Palomares, Jessica Beltran, Tomas Chivato, et al. 2020. “Efficacy and Safety of Treatment with Omalizumab for Chronic Spontaneous Urticaria ‐ a Systematic Review for the EAACI Biologicals Guidelines,” August. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....9e7c579a5a794a5e21fc4b8622648fdd&authtype=sso&custid=ns315887.